SCHEMBL6002560

SCHEMBL6002560

CCCCOc1ccc(C(O)c2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1

nearest known ligand 0.48

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ FAAH O00519 2/20 0.48
▸ MEN1 O00255 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ PPARG P37231 2/20 0.42
▸ PPARA Q07869 2/20 0.42
▸ PTGES O14684 1/20 0.42
▸ ALOX5 P09917 1/20 0.42
▸ RHOC P08134 1/20 0.41
▸ RHOA P61586 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ LTA4H P09960 1/20 0.41
▸ NR5A1 Q13285 1/20 0.41
▸ SLC2A1 P11166 2/20 0.40
▸ PPARD Q03181 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6002774 0.84 FAAH (0.46) FAAHPPARGPPARAPTGESALOX5
SCHEMBL2088414 0.83 FAAH (0.48) FAAHPPARGPPARAPTGESALOX5
SCHEMBL13303326 0.83 LTA4H (0.55) MAPK1SMN1; SMN2LTA4HNR5A1SLC2A1
SCHEMBL28983023 0.78 NR5A1 (0.65) LTA4HNR5A1SLC2A1
SCHEMBL533759 0.78 NR5A1 (0.65) LTA4HNR5A1SLC2A1
SCHEMBL12409185 0.76 CHRNB2 (0.54) PPARALTA4HNR5A1
SCHEMBL6002773 0.75 RHOC (0.48) FAAHRHOCRHOALTA4H
SCHEMBL15000370 0.75 LTA4H (0.47) FAAHMAPK1SMN1; SMN2LTA4HNR5A1
SCHEMBL5016258 0.75 FAAH (0.48) FAAHPPARGALOX5RHOCRHOA
SCHEMBL26035837 0.75 PSEN1 (0.46) FAAHPPARGPPARAPTGESALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678185-A1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-07-12 — — EP disclosed
WO-2005042542-A1 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-05-12 — — WO disclosed
Send feedback